Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study

• Principais autores: Rocco Mollace (Autor), Micaela Gliozzi (Autor), Roberta Macrì (Autor), Annamaria Tavernese (Autor), Vincenzo Musolino (Autor), Cristina Carresi (Autor), Jessica Maiuolo (Autor), Carolina Muscoli (Autor), Carlo Tomino (Autor), Giuseppe Maria Rosano (Autor), Massimo Fini (Autor), Maurizio Volterrani (Autor), Bruno Silvestrini (Autor), Vincenzo Mollace (Autor)
• Formato: Livro
• Publicado em: MDPI AG, 2022-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Low-dose aspirin represents the best option in the secondary prevention of coronary artery disease, but its extensive use in primary prevention is limited by the occurrence of gastric mucosal lesions and increased risk of bleeding. We investigated the safety profile of a novel sublingual aspirin for...